Coya Therapeutics reported total assets of $39.32M and total liabilities of $5.75M for the quarter ended Sep 2026, up 22.7% year over year. This balance sheet covers 20 quarters of results from Dec 2021 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 4.34M | 5.93M | 16.32M | 13.10M | 10.89M | 32.63M | 36.00M | 36.60M | 31.10M | 38.34M | 35.53M | 29.80M | 28.13M | 46.82M | 50.72M | 43.20M | 35.80M | |||
| Cash & Current Investments | 4.34M | 5.93M | 16.32M | 13.10M | 10.89M | 32.63M | 36.00M | 36.60M | 31.10M | 38.34M | 35.53M | 29.80M | 28.13M | 46.82M | 50.72M | 43.20M | 35.80M | |||
| Receivables - NetNet Receivables | 7.50M | |||||||||||||||||||
| Receivables - OtherOther Receivables | -0.01M | -0.15M | ||||||||||||||||||
| Receivables | 7.49M | |||||||||||||||||||
| Current Deferred Tax AssetsCurrent Deferred Tax | -3.14M | -5.63M | -8.13M | -13.31M | ||||||||||||||||
| Prepaid Assets | 0.24M | 1.25M | 1.01M | 1.29M | 0.94M | 1.07M | 1.34M | 3.31M | 4.45M | 5.97M | 2.84M | 3.67M | 3.89M | 3.12M | 2.54M | 3.88M | 3.27M | |||
| Current Assets | 4.58M | 7.18M | 17.33M | 14.39M | 11.82M | 41.20M | 37.33M | 39.89M | 35.51M | 44.31M | 38.37M | 33.43M | 32.02M | 49.94M | 53.26M | 47.06M | 39.07M | |||
| Non-Current Assets | ||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.12M | 0.09M | 0.09M | 0.08M | 0.07M | 0.07M | 0.06M | 0.05M | 0.05M | 0.04M | 0.03M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.00M | |||
| Goodwill | 1,793.73M | 1,535.85M | 1,372.23M | 2,007.98M | 2,247.98M | 1,996.83M | 1,753.09M | 1,518.95M | ||||||||||||
| Intangibles | 0.05M | 0.05M | 0.04M | 0.04M | ||||||||||||||||
| Goodwill & Intangibles | 0.05M | 0.05M | 1,793.77M | 1,535.85M | 1,372.23M | 2,007.98M | 2,248.02M | 1,996.83M | 1,753.09M | 1,518.95M | ||||||||||
| Other Non-Current Assets | 0.09M | 1.12M | 2.95M | 1.67M | 1.54M | 0.24M | 0.24M | |||||||||||||
| Non-Current Assets | 0.21M | 1.21M | 0.09M | 0.08M | 0.07M | 0.07M | 0.06M | 0.05M | 0.05M | 0.04M | 0.03M | 0.02M | 0.02M | 0.01M | 0.01M | 0.25M | 0.25M | |||
| Assets | 4.79M | 8.40M | 17.42M | 14.47M | 11.90M | 41.26M | 37.39M | 39.94M | 35.55M | 44.35M | 38.40M | 33.45M | 32.04M | 49.95M | 53.27M | 47.31M | 39.32M | |||
| Liabilities | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payables | 0.86M | 1.82M | 0.54M | 0.24M | 0.63M | 1.16M | 1.59M | 1.88M | 0.34M | 1.59M | 1.69M | 0.93M | 1.11M | 1.06M | 0.95M | 1.09M | 2.45M | |||
| Payables | 0.86M | 1.82M | 0.54M | 0.24M | 0.63M | 1.16M | 1.59M | 1.88M | 0.34M | 1.59M | 1.69M | 0.93M | 1.11M | 1.06M | 0.95M | 1.09M | 2.45M | |||
| Accumulated Expenses | 0.29M | 2.01M | 0.72M | 0.98M | 1.17M | 2.97M | 2.04M | 1.00M | 1.41M | 1.39M | 1.81M | 2.84M | 1.64M | 3.61M | 1.36M | 1.19M | 1.78M | |||
| Other Accumulated Expenses | 0.69M | 0.84M | 0.04M | |||||||||||||||||
| Current Taxes | 0.72M | 0.72M | ||||||||||||||||||
| Current Deferred Revenue | 0.92M | 0.69M | 0.94M | 0.57M | 0.85M | 0.84M | 0.73M | 0.92M | 1.20M | 1.24M | 1.23M | 1.16M | ||||||||
| Total Current Liabilities | 1.15M | 3.82M | 1.27M | 1.22M | 1.81M | 5.05M | 4.32M | 3.83M | 2.32M | 3.82M | 4.34M | 4.50M | 3.67M | 5.87M | 3.55M | 3.51M | 5.39M | |||
| Non-Current Liabilities | ||||||||||||||||||||
| Convertible Debt | 1.04M | 1.04M | 12.97M | 12.97M | ||||||||||||||||
| Non-Current Deferred Revenue | 0.57M | 0.68M | 0.86M | 1.22M | 0.95M | 0.69M | 0.64M | 1.09M | 1.05M | 0.75M | 0.52M | |||||||||
| Preferred Stock Liabilities | 1.32M | 1.32M | ||||||||||||||||||
| Other Non-Current Liabilities | 0.09M | 0.09M | 2.17M | 2.17M | ||||||||||||||||
| Total Non-Current Liabilities | -0.95M | -0.37M | ||||||||||||||||||
| Total Liabilities | 1.15M | 16.79M | 1.27M | 1.22M | 1.81M | 5.63M | 5.00M | 4.68M | 3.54M | 4.77M | 5.04M | 5.14M | 4.76M | 6.92M | 4.30M | 4.03M | 5.75M | |||
| Shareholder's Equity | ||||||||||||||||||||
| Common Equity | 3.64M | 1.96M | -1.41M | -5.36M | -8.39M | 16.15M | 13.25M | 10.09M | 35.64M | 32.39M | 35.26M | 32.01M | 39.58M | 33.37M | 28.31M | 27.28M | 43.03M | 48.97M | 43.28M | 33.57M |
| Liabilities and Shareholders Equity | 4.79M | 8.40M | 17.42M | 14.47M | 11.90M | 41.26M | 37.39M | 39.94M | 35.55M | 44.35M | 38.40M | 33.45M | 32.04M | 49.95M | 53.27M | 47.31M | 39.32M | |||
| Retained Earnings | -5.62M | -17.87M | -20.61M | -23.70M | -27.12M | -25.86M | -30.91M | -33.80M | -37.82M | -40.74M | -48.04M | -54.14M | -56.30M | -61.96M | -69.20M | -75.81M | -86.43M | |||
| Preferred Shares | 8.79M | 8.79M | 8.79M | 8.79M | 8.79M | 8.79M |
Pull Coya Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=COYA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "COYA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=COYA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();